Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding Regulus Therapeutics Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 69 | 1 | 75 | +7 |
| Shares | 53.5M | 85.6K | 54.6M | +1.13M (+2.1%) |
| Value | $84.5M | $135.3K | $107.0M | +$22.6M (+26.8%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Regulus Therapeutics Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 2,694,044 | $4.71M | 0.05% |
| Driehaus Capital Management LLC | 958,345 | $1.68M | 0.02% |
| Sphera Funds Management Ltd. | 452,845 | $792.5K | 0.20% |
| Nuveen, LLC | 85,602 | $149.8K | 0.00% |
| AQR Capital Management LLC | 68,580 | $120.0K | 0.00% |
| Oppenheimer & Co Inc | 55,000 | $96.3K | 0.00% |
| CIBC World Markets Corp | 14,013 | $24.5K | 0.00% |
| XTX Topco Ltd | 11,418 | $20.0K | 0.00% |
| Prospera Financial Services Inc | 11,058 | $19.4K | 0.00% |
| HRT Financial LP | 10,952 | $19.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 4,088 | $7.15K | 0.00% |
| Deutsche Bank AG | 2,252 | $3.94K | 0.00% |
| Point72 (DIFC) Ltd | 1,608 | $2.81K | 0.00% |
| Legacy Wealth Managment, LLC | 90 | $158 | 0.00% |
| True Wealth Design, LLC | 60 | $105 | 0.00% |
Sold out (8)
Institutions that held Regulus Therapeutics Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Millennium Management LLC | 2,192,158 | $3.46M |
| Adage Capital Partners GP, L.L.C. | 2,000,000 | $3.16M |
| Ra Capital Management, L.P. | 336,843 | $532.2K |
| PEAK6 LLC | 60,000 | $94.8K |
| Two Sigma Investments, LP | 22,264 | $35.2K |
| Commonwealth Equity Services, LLC | 11,700 | $18.0K |
| Continuum Advisory, LLC | 300 | $474 |
| Lazard Asset Management LLC | 122 | $0 |
Not filed for Q1 2025 yet (1)
Institutions that held Regulus Therapeutics Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 85,602 | $135.3K |